Indefinite Delivery Contract 75F40118D10209
Award Date
9/27/18
Last Date to Order
9/26/23
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Source Healthcare Analytics LLC with a potential value of $45 million. Under the contract, Source Healthcare will provide the FDA access to outpatient prescription and patient level drug utilization data over a five-year period ending in May 2025. Task Order 1 was issued with a firm fixed price value of $20.2 million. Source Healthcare will support the FDA's efforts...
The Drug Enforcement Administration (DEA) awarded a $1,031,685.80 Blanket Purchase Agreement (BPA) to the University of North Texas Health Science Center at Fort Worth (UNTHSC), a U.S. state government entity and educational institution, to conduct investigational studies and provide methodology for evaluating the abuse potential of synthetic opioids and other depressant drugs. This 5-year single-award IDV contract, with no set-aside, is managed by the DEA's Diversion Control Division and is...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract has a potential value of $5,000,000 and period of performance through July 2027. Task orders issued to date include $92,034 for finalizing a clinical trial protocol and $103,767 to assist in developing new contraceptive products...
The federal contract IDV awarded by the Defense Advanced Research Projects Agency (DARPA) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, is a $1,250,000.00 Other Transaction Agreement for the ALERT WARFIGHTER ENABLEMENT (AWARE) PHASE 0 program. This contract supports preclinical research services related to infectious disease research, including developing animal models, generating specialized reagents, and evaluating...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to We Pharma, Inc., doing business as WEP Clinical, with a potential value of $9.5 million. The contract has no set-aside designation and is a single-award arrangement to provide currently marketed drug products for FDA research studies from September 2020 through September 2025. Under this contract, WEP Clinical has received multiple firm fixed price delivery orders to supply...
The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, holds an Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID) to develop and utilize animal and animal replacement models for evaluating countermeasures against infectious diseases. This $146.3 million single-award IDC has a 7-year ordering period and covers four task areas: small animal models, non-human primate models,...
This indefinite delivery contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific, provides regulatory consulting assistance and research and development support for medical device development projects under the Blueprint MedTech (BPMT) program. The contract has a ceiling value of $24 million over a 5-year ordering period from September 2022 to...
The Indefinite Delivery Contract (IDC) CFP-15-D-00005 was awarded by the Consumer Financial Protection Bureau (CFPB) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract falls under the parent IDIQ contract "CFPB Economic Research" and does not have a set-aside designation. The contract aims to provide a range of preclinical research services to support the National Institute of Allergy and...
The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, was awarded a single-award Indefinite Delivery Contract (IDC) worth up to $2,303,889.50 by the Defense Contract Audit Agency (DCAA) to provide educational services. The contract has an ordering period through September 21, 2025. Under this IDC, the University of Pennsylvania has received several firm-fixed price delivery orders to develop and deliver leadership training...
The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) in February 2022. The $2,781,317 contract covers the synthesis and distribution of opioid and related peptides over a 5-year period of performance from February 15, 2022 to February 14, 2027. Polypeptide Labs, a specialized manufacturer of...